Date Title  
May 13, 2021
Summary ToggleSol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
 
Apr 27, 2021
Summary ToggleSol-Gel Technologies Provides Update on FDA Review of EPSOLAY®
 
Mar 04, 2021
Summary ToggleSol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update
 
Feb 24, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences Conference
 
Jan 11, 2021
Summary ToggleSol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect Conference
 
Dec 07, 2020
Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne Vulgaris
 
Nov 12, 2020
Summary ToggleSol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
 
Nov 09, 2020
Summary ToggleSol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020
 
Nov 04, 2020
Summary ToggleSol-Gel Technologies to Report Third Quarter 2020 Financial Results on November 12, 2020
 
Sep 10, 2020
Summary ToggleSol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea
 
Displaying 31 - 40 of 97 results